Anavex Life Sciences Corp (NASDAQ:AVXL)

3.30
Delayed Data
As of May 24
 -0.26 / -7.30%
Today’s Change
1.25
Today|||52-Week Range
4.35
+111.54%
Year-to-Date
No recent news for Anavex Life Sciences Corp.

Today’s Trading

Previous close3.56
Today’s open3.62
Day’s range3.22 - 3.62
Volume443,971
Average volume (3 months)348,316
Market cap$161.1M
Data as of 4:00pm ET, 05/24/2019

Growth & Valuation

Earnings growth (last year)-18.42%
Earnings growth (this year)-71.79%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book7.35

Competitors

 Today’s
change
Today’s
% change
BCLIBrainstorm Cell Ther...-0.04-0.94%
ORGSOrgenesis Inc-0.05-1.14%
HTGMHTG Molecular Diagno...+0.08+3.60%
AEZSAEterna Zentaris Inc-0.05-1.57%
Data as of 4:00pm ET, 05/24/2019

Financials

Next reporting dateAugust 5, 2019
EPS forecast (this quarter)-$0.17
Annual revenue (last year)$0.00
Annual profit (last year)-$17.5M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO, Secretary &
Director
Christopher U. Missling
Senior Vice President-
Operations
Stephan Toutain
Corporate headquarters
New York, New York

Forecasts